About Avrio Biopharma
Avrio Biopharma is a company based in Irvine (United States) founded in 2008 was acquired by Nitto in October 2016. Avrio Biopharma operates in a competitive market with competitors including Exela Pharma, August Bioservices, ApiJect, Gland Pharma and Vetter Pharma, among others.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Avrio Biopharma
Detailed funding history for Avrio Biopharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Avrio Biopharma
Avrio Biopharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Nitto.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified materials are manufactured and supplied for various industries.
|
Locked | Locked | Locked |
Investor details for Avrio Biopharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avrio Biopharma
Investment portfolio details for Avrio Biopharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avrio Biopharma
Detailed financials for Avrio Biopharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avrio Biopharma Comparisons
Peer comparison for Avrio Biopharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avrio Biopharma
Avrio Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, August Bioservices, ApiJect, Gland Pharma and Vetter Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| Locked | Locked | Locked |
Diversified research services for clinical solutions are offered.
|
|
| Locked | Locked | Locked |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| Locked | Locked | Locked |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| Locked | Locked | Locked |
CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.
|
|
| Locked | Locked | Locked |
Developer and manufacturer of pharmaceutical products
|
Detailed competitors of Avrio Biopharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avrio Biopharma
Complete news archive for Avrio Biopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avrio Biopharma
Avrio Biopharma was founded in 2008.
Avrio Biopharma is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Avrio Biopharma was established in 2008 in Irvine, United States, as an injectables contract development and manufacturing organization. Services encompassed cGMP manufacturing, product development, and CMC support within the biopharmaceutical sector. Operations included formulation development, fill and finish processes, clinical supply management, and lyophilization. The company was acquired by Nitto Denko Avecia in October 2016.
Avrio Biopharma's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
Avrio Biopharma has 1 investor. Key investors include Nitto.